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Endothelial Differentiation of Adipose-Derived Stem Cells
from Elderly Patients with Cardiovascular Disease
Ping Zhang, Neil Moudgill, Eric Hager, Nicolas Tarola, Christopher DiMatteo,
Stephen McIlhenny, Thomas Tulenko, and Paul J. DiMuzio
Adipose-derived stem cells (ASCs) possess significant therapeutic potential for tissue engineering and regen-
eration. This study investigates the endothelial differentiation and functional capacity of ASCs isolated from
elderly patients. Isolation of ASCs from 53 patients (50–89 years) revealed that advanced age or comorbidity did
not negatively impact stem cell harvest; rather, higher numbers were observed in older donors (>70 years) than
in younger. ASCs cultured in endothelial growth medium-2 for up to 3 weeks formed cords upon Matrigel and
demonstrated acetylated-low-density lipoprotein and lectin uptake. Further stimulation with vascular endo-
thelial growth factor and shear stress upregulated endothelial cell-specific markers (CD31, von Willebrand
factor, endothelial nitric oxide synthase, and VE-cadherin). Inhibition of the PI3K but not mitogen-activated
protein kinase pathway blocked the observed endothelial differentiation. Shear stress promoted an anti-
thrombogenic phenotype as demonstrated by production of tissue-plasminogen activator and nitric oxide, and
inhibition of plasminogen activator inhibitor-1. Shear stress augmented integrin a5b1 expression and subse-
quently increased attachment of differentiated ASCs to basement membrane components. Finally, ASCs seeded
onto a decellularized vein graft resisted detachment despite application of shear force up to 9 dynes. These
results suggest that (1) advanced age and comorbidity do not negatively impact isolation of ASCs, and (2) these
stem cells retain significant capacity to acquire key endothelial cell traits throughout life. As such, adipose tissue
is a practical source of autologous stem cells for vascular tissue engineering.
Introduction
Use of adult stem cells for vascular tissue engineeringand regeneration continues to gain momentum as re-
search reveals their improved potency and function. The
majority of work involves mesenchymal stem cells (MSCs)
derived from bone marrow aspiration and endothelial pro-
genitor cells (EPCs) obtained from blood. Each of these cell
types have been used to line vascular scaffolds in the creation
of a tissue engineered bypass graft [1–3], as well as in various
strategies to promote therapeutic angiogenesis in the coro-
nary and peripheral circulations [4–7]. Although these cells
are appropriate for vascular tissue engineering, their avail-
ability in patients most likely to benefit from this technology
raises practical concerns. The number of stem and progenitor
cells derived from bone marrow and blood decrease signifi-
cantly with age and patient comorbidity [8–10]. Further,
it has also been suggested that differentiation potential of
bone-marrow-derived MSCs decreases with age [11]. Recent
data also indicate that EPC function is diminished in patients
with severe vascular disease and multiple coronary risk
factors [12,13].
An alternative source for autologous adult stem cells is
adipose tissue. Adipose-derived stem cells (ASCs) are multi-
potent, with the capacity to differentiate into adipocytes,
chondrocytes, osteocytes, hepatocytes, and neurons, among
other cell types [14–16]. Our group has examined the differ-
entiation of ASCs into vascular cells, including both endo-
thelial cells (ECs) and smooth muscle cells, for the purposes of
vascular tissue engineering [17,18]. It is not clear in the liter-
ature if these stem cells, which closely resemble MSCs derived
from bone marrow, share the limitations noted above for stem
cells isolated from bone marrow or blood. ASCs are routinely
derived from liposuction specimens, and given the majority of
patients undergoing liposuction are relatively younger and
healthier compared to those with coronary and peripheral
arterial disease, it is possible that the usefulness of ASCs in the
latter population may also be limited.
This study evaluates the availability and subsequent en-
dothelial differentiation and function of ASCs isolated from
elderly patients with vascular disease. Herein, we isolated
ASCs from 53 patients aged 50–87 years undergoing elective
vascular surgical procedures. Using both growth factors and
shear stress, we describe the acquisition of various specific
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EC markers and phenotypes by these stem cells over a 3-
week period. The role of the PI3 and mitogen-activated
protein kinase (MAPK) signaling pathways in stem cell dif-
ferentiation is also evaluated. Lastly, we evaluate the at-
tachment of the cells on fibronectin in vitro and retention of
ASCs onto a decellularized vein exposed to shear force ex
vivo. Taken together, these studies demonstrate the useful-
ness of ASCs isolated from patients most likely to benefit
from their use in cardiovascular tissue engineering.
Materials and Methods
Study subjects
Patients scheduled for elective vascular surgery were
asked to donate up to 15 g of fat under a protocol approved
by the Institutional Review Board of Thomas Jefferson Uni-
versity. After obtaining informed consent, patient demo-
graphics were collected, including age, gender, race, height,
weight, operation to be performed, known history of dia-
betes, cardiovascular disease (defined as history of myocar-
dial infarction, angina, or coronary artery revascularization),
and smoking history. A total of 53 patients with an average
age 66 1 years (range 50–89 years) were enrolled for study.
Isolation and culture of ASCs
Adipose tissue was obtained by liposuction of the peri-
umbilical subcutaneous tissues at the beginning of the vas-
cular procedure. Through a stab incision in the lower
umbilicus, 60mL of tumescence solution (30mL 1% lido-
caine, 30mL 0.5% bupivicaine, 10mL 4.2% sodium bicar-
bonate, and 1mg epinephrine in 1 L normal saline) was
infiltrated. Using a Mercedes cannula, up to 60mL of li-
poaspirate was obtained, put on ice, and transported to the
laboratory. The lipoaspirate was washed with phosphate-
buffered saline (PBS), filtered through a 250mm sieve, and
incubated for 1 h at 378C with collagenase I solution
[1mg=mLþ4mg=mL bovine serum albumin (BSA); Wor-
thington], as previously described.17 The slurry was centri-
fuged for 10min at 1,500 g followed by a wash with 0.1%
BSA (Sigma). The resultant pellet, named the stromal vas-
cular fraction, was suspended in the expansion medium
containing M199 (Mediatech), HEPES buffer, heparin sulfate
(7.5U=mL), and 13% fetal bovine serum (Gemini Bio Pro-
ducts), and plated onto a gelatin-coated T-75 flask (Fisher
Scientific) at 378C with 5% CO2 atmosphere. Nonadherent
cells were removed after 24 h and the culture medium was
subsequently replaced twice weekly.
After reaching near-confluency (average 7–10 days), the
primary isolate underwent negative selection to remove
coisolated CD31 (micro-ECs) and CD45 (leukocytes)-positive
cells using magnetic-activated cell sorting (Miltenyi Biotec).
The cells were sequentially mixed with MicroBeads attached
to CD31 and CD45 antibodies for 15min at 48C. After
washing with buffer (PBS with 2mM EDTA and 0.5% BSA),
the CD31- and CD45-positive cells were removed by an LS
separation column. The flow-through cells (those negative
for CD31 and CD45), defining the ASC population, were
counted using a Coulter counter (Beckman; Coulter), yield-
ing the number of ASCs isolated per gram of fat initially
harvested. The ASCs were subsequently cultured in T75
flasks with the expansion medium, fed 3 times=week, and
split 1:3 when 80% confluent. The cells were submitted for
experimentation at passages 3–5.
Flow cytometry
Cell surface antigens were characterized by flow cytome-
try. The cells were detached with trypsin (0.25% with 0.1%
EDTA in HBSS) and suspended in cold staining buffer. Ap-
proximately 5105 cells were incubated with fluorescence-
conjugated antibodies for 30min. The antibodies used
were CD13 (APC-conjugated), CD29 (PE-Cy5-conjugated),
CD31 (PE-conjugated), CD44 (PE-Cy5-conjugated), CD45
(FITC-conjugated), CD73 (FITC-conjugated), CD90 (FITC-
conjugated), CD105 (PE-conjugated), and von Willebrand
factor (vWF). All the antibodies were obtained from BD
Biosciences. Isotype antibodies served as controls to exclude
nonspecific binding. Quantitative analysis was performed
using FACScalibur flow cytometer (Beckman) and FlowJo
software.
Multipotency of ASCs
To demonstrate that the cultured cells are multipotent,
differentiation into both adipocytes and osteocytes was
performed. For adipogenic differentiation, ASCs were cul-
tured for 3 weeks in NH AdipoDiff Medium (Miltenyi Bio-
tec) per manufacturer’s instructions. Differentiated cells were
then incubated with cooled methanol for 5min and stained
with fresh Oil Red O solution for 20min. Light microscopy
was used to identify lipid droplets within the cultures. For
osteogenic differentiation, ASCs were cultured for 3 weeks in
NH OsteoDiff Medium (Miltenyi Biotec) per manufacturer’s
instructions. Differentiated cells were then stained for alka-
line phosphatase activity with NBT substrate (Sigma). Light
microscopy was used to identify a typical ruptured mor-
phology within the cultures.
Endothelial differentiation of ASCs
To stimulate endothelial differentiation, ASCs were cul-
tured for up to 3 weeks in endothelial growth medium-2
(EGM-2; Lonza) with SingleQuots containing vascular en-
dothelial growth factor (VEGF), human basic fibroblast
growth factor (hFGF-b), epidermal growth factor, insulin-like
growth factor-1, heparin, ascorbic acid, and 5% fetal bovine
serum. The medium was exchanged 3 times=week and cul-
tures were split 1:3 when near confluent. In separate exper-
iments, an additional 50 ng=mL VEGF was added to the
EGM-2 to evaluate the effect of VEGF supplementation on
endothelial differentiation.
To evaluate the roles of the PI3 and MAPK pathways on
endothelial differentiation, the PI3K inhibitor LY294002
(Echelon Bioscience) and MAPK inhibitor PD98059 (LC La-
boratories) were added to the EGM-2, respectively, for a final
concentration 15mM each. These have been previously
shown to specifically inhibit the respective pathways [19,20].
Introduction of shear stress in vitro
Shear stress experiments were performed using an orbital
shaker as described by Dardik et al. [21]. ASCs cultured in
EGM-2 for 2 weeks were seeded onto 6-well tissue culture
plates (Fisher Scientific) at 5104 cells=cm2, seated on an
orbital shaker (Bellco Biotechnology) located in an incubator,
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and maintained at 378C and 5% CO2. The shaker plate was
rotated for 48 h at 210 cycles=min to produce 12 dyn at the
periphery of the wells.
Determination of acetylated-low-density
lipoprotein uptake
ASCs cultured in EGM-2 for 2 weeks were incubated with
DiI-labeled acetylated-low density lipoprotein (ac-LDL;
10 mg=mL; Sigma) at 378C for 2 h, fixed, and labeled with
FITC-conjugated human lectin (10mg=mL; Sigma) for 1 h.
Cultures were viewed with an immunofluorescence micro-
scope to determine uptake of ac-LDL, human lectin, or both.
Matrigel tube formation assay
ASCs cultured for 2 weeks in EGM-2 were plated on top of
Matrigel substrate (at a density of 2105=100 mL Matrigel; BD
Biosciences) and incubated at 378C in a 5% CO2 for up to
12 h. Formation of cord-like structures was observed by
phase-contrast microscopy.
Evaluation of endothelial molecular markers
Expression of EC-specific molecular markers was deter-
mined by reverse transcription (RT)-polymerase chain reaction
(PCR) and real-time PCR. Total RNA was extracted through
RNeasy mini columns (Qiagen). To detect the specific genes
expressed, RT-PCR was performed using the following prim-
ers: endothelial nitric oxide synthase (eNOS): 5-primer (50-
TCCCCCAGAACTCTTCCTT-30) and 30-primer (50-CTCATTC
TCCAGGTGCTTCA-30); vWF: 5-primer (50-TCTTCCAGGAC
TGCAACAAG-30) and 30-primer (50-TCCGAGATGTCCTCC
ACATA-30); CD31: 5-primer (50-CACAGCAATTCCTCAGG
CTA-30) and 30-primer (50-TTCAGCCTTCAGCATGGTAG-30);
VE-cadherin (CD144): 5-primer (50-ACCCCCACAGGAAAA
GAATC-30) and 30-primer (50-GACTTGGCATCCCATTGTCT-
30). Messenger RNA levels were quantified using TaqMan real-
time PCR with the 7500 Fast real-time PCR system (Applied
Biosystems). PCR primers targeting human eNOS, vWF, CD31,
VE-cadherin, and tissue-plasminogen activator (tPA) and Taq-
Man probes were obtained from Applied Biosystems. PCR
conditionswere 488C for 30min, 958C for 10min, followed by 40
cycles of 958C for 15 s and 608C for 1min. The housekeeping
gene GAPDH was amplified in separate tubes to normalize for
variance in input RNA. The level of target mRNA in samples
was estimated by the relative standard method with a series of
dilutions of RNA from human vascular cells.
Western blot analysis
Whole cell lysates (50 mg) of cells were resolved on 4%–12%
sodium dodecyl sulfate–polyacrylamide gel electrophoresis
acrylamide gel (Invitrogen). Proteins were transferred on
polyvinylidene fluoride (PVDF) membranes and imagedwith
the infrared imaging Odyssey system (LI-COR Biosciences).
Monoclonal anti-CD31 and anti-actin were obtained from
Santa Cruz Biotechnology.
Determination of plasminogen activator
inhibitor-1 expression
Concentration of plasminogen activator inhibitor-1 (PAI-1)
proteins in the cell culture supernatant was quantified using
a quantitative sandwich ELISA kit (R&D Systems) per the
manufacturer’s instructions. Samples were evaluated on the
ELISA plate reader at 450 nm with corrections at 570 nm. A
highly linear calibration curve (r2> 0.99) was obtained.
Measurement of nitric oxide production
Nitric oxide (NO) production by differentiated ASCs was
measured within the supernatant of cultured cells before and
after stimulation with shear stress for 48 h. The metabolic
product NO and its oxidative metabolic products, NO2 and
NO3 (collectively known as NOx), were determined using a
chemiluminescent NO detector (SIEVER 280i NO Analyzer)
as described by Gao et al. [22].
Attachment studies
To determine stem cell attachment to vascular basement
membrane components in vitro, ASCs (50,000 cells=well)
were plated onto 96-well culture plates coated with
18mg=mL fibronectin (BD Biosciences). At various time
points over a 24 h period, the unattached cells were removed
and counted by gently washing with PBS; the remaining
adherent cells were stained with crystal violet for 5min.
After eluting the absorbed crystal violet with 0.1M sodium
citrate, absorbance within the eluate was measured on the
plate reader at 570 nm. The number of cells attached was
then calculated by comparison with a standard curve gen-
erated using known numbers of cells.
To determine stem cell attachment to vascular basement
membrane ex vivo, intact human saphenous vein speci-
mens procured within 24 h of autopsy (National Disease
Research Interchange) were divided into segments 4–5 cm
in length. The segments were decellularized by incubation
in 0.075% sodium dodecyl sulfate for 15 h, leaving the
vascular basement membrane and extracellular matrix in-
tact, as previously described by us.23 Decellularized vein
segments were opened longitudinally and pinned lumen
side up within a seeding chamber. Cells were seeded onto
the surface of the vascular basement membrane at 4105
cells=cm2 and incubated at 378C for up to 24 h. Cell at-
tachment was quantified indirectly by counting the number
of residual cells in the seeding medium after gentle washing
with PBS.
The effect of shear force on cell retention after seeding
onto a decellularized vein was determined using a biore-
actor and flow conditioning system (Lab VIEW; National
Instruments) as described by McIlhenny et al. [23]. Briefly,
the luminal surface of a decellularized human saphenous
vein (5 cm in length) was precoated with fibronectin
(18 mg=mL; BD Bioscience) for 1 h at 378C with rotation.
ASCs were placed into the lumen of vessel at a concentra-
tion of 2105=cells cm2 luminal surface area and incubated
for 2 h with rotation. After 24 h of fluid exchange through
the graft (<0.1 dyne), flow within the graft was increased
linearly over 5 days whereupon a total of 9 dynes was
reached. The graft was removed from the chamber, and
splayed open. The morphology of the attached cells was
determined after staining the live, seeded cells with Cell-
Tracker Green (Molecular Probes) for 20min and viewing
the specimens en face using a laser confocal microscope
(Olympus Fluoview).
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Integrin studies
Integrin expression was determined using the Alpha=Beta
Integrin-Mediated Cell Adhesion Array Combo Kit (Chemi-
con International) according to manufacturer’s instructions.
Integrin blockade was accomplished by pretreating differ-
entiated ASCs with anti-a5b1 human monoclonal antibodies
(Chemicon International) for 1 h before seeding the cells onto
fibronectin-coated plates, as above.
Statistical analyses
Data are expressed as mean standard error. A two-tailed
Student’s t-test was used for 2 group comparisons. The sta-
tistical significance regarding multigroup comparisons was
determined using one-way analysis of variance. A value of
P< 0.05 was considered statistically significant.
Results
Isolation of ASCs from elderly patients
To determine the influence of advancing age on stem cell
isolation, ASCs were isolated from a total of 53 patients with
an average age of 66 1 years (range 50–89 years). Figure 1A
describes the characteristics of the experimental population.
The patients had a significant amount of atherosclerosis risk
factors, including diabetes (36%) and smoking (25%), with
70% having known cardiovascular disease.
From the population as a whole, we isolated an average
of 1.5 million 0.5 ASCs per gram of adipose tissue initially
harvested. Upon separating the data by age decade (Fig.
1B), we observed that the number of ASCs per gram was
significantly higher in the patients over 60 years old com-
pared to the 50–59-year-old group (P< 0.05), resulting in a
positive correlation between ASC availability and patient
age (Fig. 1C; r¼ 0.2, P¼ 0.09). Univariate analysis of the
individual risk factors failed to reveal any significant cor-
relation between ASC harvest and the presence of cardio-
vascular disease, diabetes, smoking, obesity (BMI > 30), or
gender (Fig. 1D).
Cell surface markers and multipotency of ASC
Surface marker expression of the culture-expanded ASCs
was analyzed by flow cytometry. ASCs were strongly posi-
tive for CD13 (98.4%), CD29 (77.4%), CD44 (97.6%), CD73
(76.1%), CD90 (97.1%), and CD105 (96.4%), markers consis-
tent with those found on MSCs (Fig. 2A). CD31 and CD45
were not found in culture-expanded ASCs after removed the
CD31- and CD45-positive cells by magnetic-activated cell
sorting (data not shown). The ability of ASCs harvested from
elderly patients to differentiate into several cell lines was
examined. In addition to endothelial differentiation (see
studies below), ASCs were grown in either adipogenic or
osteogenic medium for 3 weeks and subsequently stained
with Oil Red O or for alkaline phosphatase, respectively.
FIG. 1. Isolation of ASCs from elderly patients with cardiovascular disease. (A) Overall patient characteristics. (B) Number
of ASCs isolated per gram of adipose tissue compared with patient age subdivided into decades. (C) Overall correlation
between the number of ASCs isolated per gram of adipose tissue and patient age (n¼ 53). (D) Univariate analysis comparing
isolation number and various patient characteristics. ASCs, adipose-derived stem cells; N.S., not significant.
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Figure 2B reveals that the stem cells have differentiated into
either adipocytes or osteocytes, suggesting that ASCs from
elderly patients retain their multipotency.
Acquisition of endothelial characteristics
by ASCs
We induced endothelial differentiation by culturing ASCs
in EGM-2. After 2 weeks of culture, ASCs newly expressed
the messenger RNA for the endothelial-specific markers
vWF, platelet=endothelial cell adhesion molecule (CD31),
eNOS, and VE-cadherin (CD144). Supplementing the EGM-2
with addition VEGF (50 ng=mL) further increased expression
of vWF and eNOS demonstrated by quantitative real-time
PCR (Fig. 3A, left). Notably, expression of vWF approached
the levels noted in endothelial controls. Flow cytometry and
western blotting analysis confirmed protein expression of
vWF and CD31 in ASCs after 2 weeks of culture in EGM-2
(Fig. 3A, right). Differentiated ASCs stained positive for both
DiI-ac-LDL and human lectin, confirming their ability to
engulf ac-LDL (Fig. 3B). They also newly formed capillary-
like structures when plated onto Matrigel (Fig. 3C) similar to
that of control ECs (Fig. 3D).
Inhibition of PI3K blocks the endothelial differentiation
of ASCs
To investigate possible intracellular pathways involved in
the observed endothelial differentiation of ASCs, we evaluated
the effects of inhibiting either the PI3K or MAPK pathways,
both of which have been shown to be involved with differen-
tiation [9,20,24,25]. To do this, we added to the differentiation
medium either specific PI3K (LY294002) or MAPK (PD98059)
inhibitors and subsequently evaluated the ability of the cells to
form capillary-like structures on Matrigel as well as to express
EC molecular markers. Inhibition of the PI3K pathway, but not
theMAPK pathway, appeared to inhibit the ability of the ASCs
to subsequently form capillary-like structures (Fig. 3E, F, re-
spectively). Similarly, inhibition of the PI3K pathway signifi-
cantly reduced mRNA expression of CD31 (*4-fold; P< 0.01)
and vWF (*2-fold; P< 0.05; Fig. 3G). These effects were not
seen with inhibition of the MAPK pathway.
FIG. 2. Immunophenotype characterization and multipotency of ASCs. (A) Representative FACS analysis of cultured ASCs
(passage 3–5) revealing the majority of ASCs express surface antigens consistent with mesenchymal stem cell markers. Plots
show the isotype control (white) versus specific antibody staining (black; n¼ 12; mean age: 67.4 3). (B) Photomicrograph of
ASCs before differentiation (left; phase contrast, 20), and after 3 weeks of culture in adipogenic (middle; Oil Red O stain, 20)
and osteogenic (right; AP stain, 20) media (n¼ 6; mean age: 68 6 years). AP, alkaline phosphatase.
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Shear stress further stimulates endothelial
differentiation of ASCs
To investigate the effect of shear stress on the endothelial
differentiation of ASCs harvested from elderly patients, we
exposed ASCs cultured in EGM-2 for 2 weeks to physio-
logical levels of shear stress (12 dynes) in vitro. After 48 h of
shear stress, the differentiated ASCs re-aligned in the direc-
tion of flow, a morphological characteristic of ECs (Fig. 4A).
Additionally, shear force significantly upregulated expres-
sion of CD31 (*1.3-fold) and vWF (*2-fold) mRNA levels
compared with static controls by real-time RT-PCR analysis
(Fig. 4B, left). Further, flow cytometry demonstrated signif-
icant increases in protein expression of CD31 (*2-fold) and
vWF (*3-fold) after exposure to shear stress (Fig. 4B, right).
Shear stress upregulates antithrombogenic markers
in differentiated ASCs
In ECs, shear stress stimulates the production of eNOS,
NO, and tPA, and inhibits the production of PAI-1, thereby
producing a nonthrombogenic phenotype. We tested this
response to shear stress in ASCs cultured for 2 weeks in
EGM-2. Although expression of eNOS mRNA was signifi-
cantly lower than that in human EC (Fig. 4C), there was
a trend (2.5-fold increase) noted in eNOS expression in
FIG. 3. Acquisition of endothelial characteristics by ASCs. (A) After culture for 2 weeks in EGM-2 (‘‘EGM2’’), expression of
each of these endothelial markers is identified (n¼ 12; mean age 69 3 years). With the addition of VEGF to the medium
(50 ng=mL; ‘‘EGM2=VEGF’’), further upregulation is noted for vWF and eNOS by quantitative real-time PCR (n¼ 5; mean age
67 6 years; *P< 0.05 vs. control EGM2). Flow cytometry and western blotting analysis demonstrated protein expression of
vWF and CD31 in differentiated ASCs (right panel). (B) Fluorescent photomicrograph (40) of differentiated ASCs revealing
concomitant uptake of Dil-labeled acetylated-low-density lipoprotein (red) and FITC-labeled human lectin (green). (C)
Photomicrograph (phase contrast, 40) of differentiated ASCs and HUVECs and (D) 24 h after plating onto Matrigel dem-
onstrating their ability to form capillary-like structures, suggesting the ability to participate in angiogenesis. (E) Photo-
micrograph (phase contrast, 40) of ASCs grown in the differentiating medium supplemented with the PI3K inhibitor
LY294002 demonstrating inhibition of capillary growth upon plating on Matrigel. (F) Photomicrograph (phase contrast, 40)
of ASCs grown in the differentiating medium supplemented with the mitogen-activated protein kinase inhibitor PD98059
conversely reveals the ability of the ASCs to form capillary-like structures. (G) Reverse transcription (RT)-PCR (left panel) and
quantitative PCR analysis (left panel) reveals that expression of both vWF and CD31 in differentiating ASCs appears sig-
nificantly inhibited by PI3K inhibition (LY) rather than mitogen-activated protein kinase inhibition (PD) (n¼ 3; mean age
72 6 years; *P< 0.05, **P< 0.01 vs. control). EGM2, endothelial growth medium-2; PCR, polymerase chain reaction; HU-
VECs, human umbilical vein endothelial cells; VEGF, vascular endothelial growth factor; vWF, von Willebrand factor.
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ASCs in response to shear stress. Notably, total NOx pro-
duction released from ASCs increased significantly (3.6-fold)
upon exposure to shear stress, a result similar to control EC
(Fig. 4D).
Similarly, shear stress stimulated production of tPA
mRNA significantly in differentiated ASCs (2.2-fold; Fig. 4E).
Conversely, the secreted PAI-1 in ASCs significantly reduced
(1.7-fold) after exposure to shear stress (Fig. 4F). Together,
these results suggest that ASCs differentiated toward EC
may acquire a nonthrombogenic phenotype in response to
shear stress.
Attachment of differentiated ASCs to vascular
basement membrane
To understand the interaction of the differentiated ASCs
with blood vessel wall components, and to further under-
stand their potential for use in vascular tissue engineering,
we investigated the attachment of these cells in vitro on
fibronectin (extracellular membrane component) and ex vivo
on decellularized human blood vessels. Regarding the latter
experiments, we have previously shown that our decel-
lularization process preserves the vascular basement mem-
brane, and in particular the resident type IV collagen [26].
Figure 5A (left) reveals that the differentiated ASCs in
vitro do attach to a fibronectin-coated surface, but not as
readily as ECs. Of note, however, after exposure to physio-
logical shear stress in vitro (12 dynes48 h), there was a
significant improvement in attachment (1.4-fold), as was also
noted with the EC controls. Given the important role they
play in EC attachment to vascular basement membrane, we
examined expression of integrins a5b1 and avb3 in ASCs (Fig.
5A, middle). We found that while both integrins were pres-
ent on the ASCs, only the a5b1 integrin was upregulated
upon exposure to shear stress (1.7-fold). To further define the
importance of the a5b1 integrin on ASC attachment, we ad-
ded a5b1 blocking antibodies to the medium before attach-
ment (Fig. 5A, right). We observed that a5b1 blockade
FIG. 4. Effects of shear stress on ASC differentiation. (A) Photomicrographs (phase contrast, 20) of differentiated ASCs
cultured under static conditions or exposed to shear stress (12 dyne48 h) revealing re-alignment in the direction of flow. (B)
Quantitative PCR (left panels) of differentiated ASCs reveals that exposure to shear stress (12 dyne48 h) significantly
upregulates expression of the EC markers CD31 and vWF (n¼ 6; mean age 67 4 years; **P< 0.01 vs. control). Flow
cytometry (right panels) confirms that shear stress upregulates protein expression of CD31 and vWF (n¼ 4; mean age 69 7
years; *P< 0.05, **P< 0.01 vs. control). (C) Quantitative PCR analysis of eNOS expression reveals a small amount of eNOS
expression in differentiated ASCs compared to EC controls (n¼ 4; mean age 65 6 years; **P< 0.01 vs. control). Although the
effect did not reach statistical significance, the application of shear stress appeared to upregulate eNOS message. (D)
Measurement of total nitric oxide (NOx) production using a chemiluminescence NO detector suggesting significant amounts
of NO production by differentiated ASCs, including stimulation by shear stress (n¼ 4; mean age 68 7 years; **P< 0.01 vs.
control). Shear stress increased tPA expression (E, quantitative PCR) and decreased PAI-1 expression (F, ELISA), suggesting
the acquisition of an antithrombogenic phenotype by the differentiated ASCs (n¼ 4; mean age 68 7 years; *P< 0.05,
***P< 0.001 vs. control). EC, endothelial cell; eNOS; endothelial nitric oxide synthase; PAI-1, plasminogen activator inhibitor-1;
tPA, tissue-plasminogen activator.
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significantly reduced ASC attachment to fibronectin under
both static and shear stress conditions.
Finally, we assessed the attachment of differentiated ASCs
to vascular basement membrane. A significant amount of
differentiated ASCs firmly adhered to the surface in as early
as 30min (50% 3% of seeded cells). After 2 h, 84% 2% of
ASCs attached and remained stable over 24 h (90% 3%).
Similar findings were noted upon using control ECs (Fig. 5B).
The attachment and retention of differentiated ASCs on de-
cellularized vein allograft was examined after seeding within
a vascular bioreactor and linearly increasing luminal shear
force to physiological levels. As shown in Fig. 5C, a nearly
confluent monolayer of differentiated ASCs remains 5 days
after seeding and increasing shear force to 9 dynes. These
results were similar to the human umbilical vein endothelial
cell-seeded control graft (Fig. 5C, right).
Discussion
In this study, we investigated the isolation of adult stem
cells derived from the adipose tissue of elderly patients with
cardiovascular disease, and the subsequent ability of these
cells to differentiate toward an endothelial lineage. The major
findings include that (1) ASCs can be isolated in abundance
from the patient population most likely to benefit from this
technology, unlike other bone marrow- or blood-borne
stem and progenitor cells, (2) ASCs from elderly patients
acquire several important EC characteristics upon culture in
FIG. 5. Attachment of differentiated ASCs to vascular basement membrane. (A) Effect of shear stress and a5b1 integrin
expression on ASC attachment. The left panel reveals that cell attachment to fibronectin by ASCs is improved by shear stress
(12 dynes48 h), but not to the degree that EC attach (n¼ 3; *P< 0.05, **P< 0.01 vs. control). Integrin-mediated cell adhesion
analysis (middle panel) demonstrates that shear stress significantly increased a5b1 expression in differentiated ASCs but not
avb3 (n¼ 3; *P< 0.05 vs. control). Specific blockade of the a5b1 integrin (right panel) significantly reduced ASC attachment to
fibronectin and eliminated the effect of shear stress (n¼ 3; **P< 0.01 vs. control). (B) Kinetics of attachment to vascular
basement membrane. Photographs of intact human saphenous vein (left) that has subsequently been decellularized for
seeding experiments. Attachment of the cells reveals that both differentiated ASCs and EC attach maximally to the scaf-
folding by 2h, and remain attached at 24 h after static seeding (right). (C) Cell retention under physiological fluid flow
conditioning. Confocal microscopy images of seeded differentiated ASCs and HUVECs on decellularized vein scaffold. Cells
were labeled using Cell Tracker Green to allow for observation. Images were taken 24 h and 5 days after seeding and linearly
increasing shear force up to 9 dynes.
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endothelial growth factors, with further upregulation of
EC-specific markers when stimulated by shear stress, (3)
endothelial differentiation appeared to be dependent upon
the PI3K but not MAPK pathway, (4) differentiated ASCs
appeared to also acquire an antithrombogenic phenotype
upon stimulation with shear stress, and (5) attachment and
retention of differentiated ASCs seeded on vascular base-
ment membrane is improved by conditioning with shear
force, a finding that appears mediated by upregulation of the
a5b1 integrin. Taken together, these results suggest that ad-
ipose tissue is a viable and robust source of autologous adult
stem cells that can be used as an EC substitute in vascular
tissue engineering=regenerative medicine strategies.
This study specifically evaluates the availability of ASCs
in an elderly patient population with the usual associated
cardiovascular comorbidities. After isolation, attachment to
tissue culture plastic, and negative selection for coisolated
CD31=45þ cells (an *1 week process), we found that an
average of 1.8 million ASCs=g of tissue can be obtained from
the abdominal wall fat of patients >70 years old. The stem
cell harvest from older patients in the study group was
higher than that from the younger patients (those 50–59
years old). We did not investigate the reason behind this
observation, but suspect this may be due to either a differ-
ence in the release of cells from adipose tissue by collagenase
between the populations, or a change in water content of the
tissue that would alter the weight of the tissue, rather than a
true expansion of the population. Because the study did not
include far younger (eg, 20–29 years old) control patients, we
cannot definitively comment upon isolation differences that
may exist with this population; nonetheless, the current
study clearly demonstrates that an abundance of cells can be
harvested from the elderly, cardiovascular patient. This may
prove to be an important advantage for ASCs over
stem=progenitor cell populations derived from bone marrow
and blood, where isolation number diminishes with ad-
vancing age and comorbidities associated with ischemic
cardiovascular disease [12,27]. This advantage may become
increasingly important as our population age advances; in
fact, the U.S. Department of Labor has estimated that there
will be 50 million Americans older than age 65 by 2015 [28].
In addition to evaluating stem cell availability with respect
to age, this study also examined the impact of gender, obe-
sity, tobacco use, and diabetes—all risk factors for cardio-
vascular disease—and cardiovascular disease itself on stem
cell isolation. The results of this study demonstrate that none
of these demographics significantly altered the isolation. Of
note, we did not evaluate the impact of various medications,
such as statins, which may have an effect on stem cells
harvest. Evaluation of the effects of patient comorbidities in
vascular tissue engineering=regenerative medicine is critical,
given that cardiovascular diseases remain the leading cause
of death worldwide [29].
In addition to confirming the availability of these stem
cells in an elderly population, this study provides evidence
for the first time that ASCs from elderly patients with car-
diovascular disease can acquire several important EC char-
acteristics. A number of studies have shown that embryonic
and adult stem cells differentiate into ECs in the presence of
soluble growth factors [17,30–33]. Using EGM-2, we dem-
onstrate that ASCs newly express the EC markers CD31,
vWF, eNOS, and VE-cadherin by 2 weeks. EGM-2 contains
up to 10 ng=mL VEGF (per manufacturer), a known stimulus
of the endothelial differentiation of endothelial progenitor
and MSCs in vitro [34–37]. We found that supplementing the
EGM-2 with additional VEGF (50 ng=mL) significantly in-
creases expression of vWF and eNOS within the stem cells.
Although we did observe new expression of all of the mo-
lecular markers tested in the differentiated stem cells at 2
weeks, we do note that expression of eNOS and VE-cadherin
message was significantly less compared with endothelial
controls. Interestingly, and despite this observation regard-
ing eNOS, NO production appeared similar to EC controls.
Further work will be necessary delineate the timeline of ex-
pression for these important EC markers.
Evaluation of the role of both the PI3K and MAPK path-
ways in endothelial differentiation revealed that the acqui-
sition of the endothelial characteristics of capillary formation
and CD31 and vWF expression appeared dependent on the
PI3K pathway. Several studies report that PI3K signaling also
mediates VEGF expression in ECs and inhibition of PI3K
signaling interferes with angiogenesis [38,39]. These findings
are consistent with those reported by Cao et al., who also
reported the importance of the PI3K pathway in the endo-
thelial differentiation of ASCs [40].
Shear force proved to be an important stimulus to upre-
gulate various endothelial markers in the ASCs. A previous
study by us revealed that shear alone does not appear to
induce differentiation; rather, it requires the presence of en-
dothelial growth factors before its effects were observed.17
Shear force may regulate expression of growth factors, and
has been implicated as playing a critical role in the physio-
logical response of blood vessels through ECs signaling
[41,42]. Other studies have demonstrated that shear stress
can stimulate differentiation of stem cells toward EC phe-
notypes [37,43,44]. In this study, expression of CD31 and
vWF at both the message and protein levels in ASCs were
upregulated by exposure to physiological levels of shear
stress (12 dynes).
In addition to stimulating various molecular markers upon
differentiation of ASCs, shear force also appeared to foster an
anti-thrombogenic phenotype. Prior studies involving shear
force demonstrate this observation in peripheral blood EPCs
[45,46]. Here we have similarly demonstrated that shear force
stimulates expression of tPA and inhibits PAI-1. Further, NO
production released from ASCs was significantly increased
by exposure to shear stress. Given the critical role ECs play in
the regulation of thrombosis within blood vessels, these
results provide evidence for the ability of ASCs to commit to
an EC lineage.
Other functional characteristics of ECs were observed in
ASCs after culture in differentiating medium. The ability to
form new capillary-like structures upon plating on Matrigel
suggests that differentiated ASCs have the potential to par-
ticipate in angiogenesis. This in vitro observation is consis-
tent with previous work by others that demonstrates the
ability of ASCs to participate in postnatal neovascularization
in vivo [47]. We also observed the uptake of ac-LDL by these
cells, a known characteristic of ECs and their circulating
progenitor cells.
In addition to evaluating endothelial differentiation ca-
pacity of ASCs isolated from elderly patients, we prelimi-
narily evaluated their multipotency. Several investigators
have demonstrated the multipotent potential of stem cells
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derived from adipose tissue [15,48–50]. As noted, however,
many of these studies were performed using adipose tissue
from healthy, young patients after cosmetic liposuction. In
this study, we preliminarily confirmed that ASCs derived
from elderly patients retained the ability to differentiate to-
ward adipocyte and osteocytes lineages, in addition to ECs.
We further investigated the attachment of differentiated
ASCs to vascular basement membrane components (specifi-
cally, fibronectin), not only to demonstrate similarity to ECs,
but also to evaluate their potential for use as EC substitutes
in the creation of tissue-engineered vascular grafts. In vivo,
ECs reside in a shear stress environment; an important
mechanism that allows the cells to remain firmly attached
and to align with blood flow is an increase in the number of
integrins as well as their affinity for specific ligands in re-
sponse to shear [51]. Flow conditioning of ECs (a gradual
introduction of shear force) has also been used to improve
attachment of the cells to vascular grafts [52]. Urbich et al.
have demonstrated that upregulation of mRNA and protein
expression of integrin subunits a5 and b1 in response to shear
leads to a functional increase of endothelial attachment
strength [53]. In the current study, we observed that differ-
entiated ASCs attached to fibronectin, but not as readily as
endothelial controls. The application of shear force before
seeding significantly improved attachment, an observation
that correlated with upregulation of the a5b1 integrin (but not
the avb3 integrin). This was further confirmed by the obser-
vation that both cell attachment and the effect of shear were
essentially eliminated with monoclonal antibody blockade of
the a5b1 integrin.
Finally, these studies evaluated the ability of differentiated
ASCs to form a confluent monolayer that resists detachment
at physiological levels of shear force. This was accomplished
using the luminal surface of decellularized human saphe-
nous vein. We have previously shown that our decellular-
ization method leaves the extracellular matrix of the vessel
intact, including the basement membrane composed pri-
marily of collagen IV [26]. Our results suggest that the dif-
ferentiated ASCs attach to the vessel with similar efficacy
and kinetics as do EC. Additionally, differentiated ASCs
formed a confluent monolayer within the vascular graft that
remained intact over 5 days as luminal flow was linearly
increased up to 9dyn. These preliminary tissue engineering
experiments provide further evidence for the similarity be-
tween the differentiated stem cells and EC, and suggests the
utility of these cells for use as EC substitutes for the creation
of vascular grafts. Further work will be necessary to evaluate
the retention and function of the ASCs in vivo.
These studies demonstrate the acquisition of a multitude
of EC characteristics upon differentiation by ASCs isolated
from elderly patients with cardiovascular disease. However,
unlike the isolation study (where data could be gathered
from all 53 patients), examination of differentiation using
low passage number cells significantly limited the number of
assays we could perform on each cell line. In total, 42 cell
lines were submitted for examination of differentiation; for
each individual test, the number of cell lines examined ran-
ged between 3 and 12. Given this study design, we can
conclude that ASCs isolated from elderly patients can com-
mit toward an EC lineage; however, we cannot definitively
state that comorbid conditions present within these patients
do not specifically alter the potency of the isolated ASCs.
In summary, this study provides new and practical in-
formation regarding the use of an adult stem cell lineage
derived from adipose tissue, namely, (1) unlike stem and
progenitor cells derived from bone marrow and blood, the
availability of these cells for use does not appear to be ad-
versely affected by age (in fact, harvest was better in the
elderly population); (2) ASCs from elderly patients acquire
many of the key molecular and functional markers associ-
ated with mature ECs, including the acquisition of an an-
tithrombogenic phenotype, in response to chemical and
physical signals; and (3) these cells readily attach to vascular
basement membrane and form a confluent monolayer of cells
within a vascular graft that resists detachment at physiologic
levels of shear force. Overall, adipose tissue appears to be a
suitable and viable source of autologous stem cells that could
be used as EC substitutes in the patient population most like
to benefit from this technology.
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